Jayanta Chatterjee

ORCID: 0000-0002-1770-4835 · 8 papers in corpus
preprint 2026
·doi:10.20944/preprints202607.1410.v1

Background: Endometriosis-associated ovarian cancers (EAOCs), including clear cell (OCCC) and endometrioid (EnOC) subtypes, frequently activate the PI3K/AKT/mTOR signaling axis. While genomic aberrations are well documented, the coordinate…

article 2026
·doi:10.1016/j.ijgc.2025.103478
2026
Archives of gynecology and obstetrics ·doi:10.1007/s00404-026-08395-2

BackgroundAccessory cavitated uterine mass (ACUM) is a rare Mullerian anomaly that predominantly affects young women, presenting with refractory dysmenorrhea. Despite 3D ultrasound and MRI being the gold standard for diagnosis, diagnostic d…

article 2026
·doi:10.1016/j.ijgc.2025.103490
2025
Molecules (Basel, Switzerland) ·doi:10.3390/molecules30163410

(1) Background: Following the discovery of the adipokine/hormone asprosin, a substantial amount of research has provided evidence for its role in the regulation of glucose homeostasis, as well as appetite, and insulin sensitivity. Its level…

review 2024
Cancers ·doi:10.3390/cancers16112160

Ovarian cancer is an umbrella term covering a number of distinct subtypes. Endometrioid and clear-cell ovarian carcinoma are endometriosis-associated ovarian cancers (EAOCs) frequently arising from ectopic endometrium in the ovary. The mech…

article 2018
International journal of molecular medicine ·doi:10.3892/ijmm.2018.3967

Endometriosis is a well‑known risk factor for ovarian cancer. The genetic changes that characterise endometriosis are poorly understood; however, the mechanistic target of rapamycin (mTOR) pathway is involved. In this study, we investigated…

letter 2012
Reproductive BioMedicine Online ·doi:10.1016/j.rbmo.2012.02.013